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COVID-19 illness may cause a dysregulated systemic inflammatory response, leading to cardiovascular
damage and an increased risk for cardiovascular disease (CVD). Physical activity (PA) is inversely
associated with systemic inflammation and CVD risk and may be a cardioprotective lifestyle factor for
individuals recovering from COVID-19. PURPOSE: 1) To compare CVD risk, assessed as arterial
stiffness and systemic inflammatory levels, between young adults recovering from COVID-19 and
uninfected controls, and 2) to explore PA as a mediator for the relationship of COVID-19 infection history
with arterial stiffness and systemic inflammation. METHODS: Analyses were performed on 23
COVID-19 (15 females, 25.0±8.9 years, 24.1±3.5 kg/m2) and 32 control participants (18 females,
24.4±6.5 years, 25.1±3.5 kg/m2). Arterial stiffness was estimated as pulse wave velocity (PWV) during
24-hour ambulatory blood pressure monitoring with an oscillometric blood pressure device. Systemic
inflammation was assessed as salivary C-reactive protein (CRP) levels using the passive drool method.
PA was objectively measured via accelerometry and assessed as moderate-to-vigorous PA (MVPA). An
independent samples t-test was used to compare measures of arterial stiffness and systemic inflammation
between the COVID-19 and control groups. Mediation analysis was used to determine whether there was
a significant indirect effect of COVID-19 infection history through MVPA on arterial stiffness and CRP
levels. RESULTS: There were no significant differences (p > 0.05) between the SARS-CoV-2 and control
groups in PWV (5.0±0.5 m/s vs. 5.1±0.5 m/s) or CRP levels (765.4±672.9 pg/mL vs. 526.3±674.8
pg/mL). Mediation analysis did not reveal a significant indirect effect of COVID-19 infection history
through MVPA on arterial stiffness (estimate = 0.02, 95% CI = -0.05 – 0.24) or CRP levels (estimate =
0.03, 95% CI = -0.07 – 0.16). CONCLUSION: These results suggest there are no differences in arterial
stiffness and systemic inflammation between young adults recovering from COVID-19 and uninfected
controls, and that MVPA may not significantly mediate the relationship for COVID-19 infection history
with arterial stiffness and systemic inflammation. Young adults recovering from COVID-19 may not have
a heightened CVD risk compared to controls.

